In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while ...

A new change was communicated in an email statement from Rene Ward, the Head of Corporate Affairs for Boehringer Ingelheim’s ...

One of St. Joseph’s top employers announced Monday that 60 employees in manufacturing and supply will no longer have roles moving forward.

President Donald Trump visited Ohio and Kentucky Wednesday afternoon on what the media has dubbed his ‘affordability tour,’ where he travels the country advocating for his economic policies ahead of ...

The preclinical, small molecule program offers a potential first-in-class, oral, precision immunometabolic approach to modulating disease-driving immune cellsDeal includes upfront and milestone ...

Boehringer Ingelheim has become the second company to get a product approved under the FDA's national priority voucher ...

The nod allows Hernexeos (zongertinib) to be used as an initial treatment option for NSCLC with HER2-activating mutations in ...

Boehringer Ingelheim acquires an exclusive license for a preclinical oral immunology program from Sitryx in a deal worth over ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsAdam Steensberg - President ...

OSE Immunotherapeutics has kicked off a strategic realignment initiative that involves deprioritizing the AbbVie-partnered OSE-230 and focusing its resources on the late-stage development of its ...

Recognized for outstanding well-being program supporting employees’ physical, mental, social, and financial health Strong results also in career ...

The preclinical, small molecule program offers a potential first-in-class, oral, precision immunometabolic approach to modulating disease-driving immune cellsDeal includes upfront and milestone paymen ...